First Report of the Prevalence of Human T-Lymphotropic Virus Type 1 (HTLV-1) for Hemodialysis Patients in Tehran

Yazdani, Reza; Dadmanesh, Maryam; Ghorban, Khodayar

doi:10.5812/archcid.65512

Cited by 2 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, HTLV-1 infection is expected to have a lower prevalence among HD patients from non-endemic parts of Iran. A study performed in Tehran among HD patients (24 to 88 years old) showed that the prevalence of HTLV-1 was 0.66% (one positive case among 150 patients) (11). In a study conducted in Mazandaran, an area with very low incidence of HTLV-1 infection in north of Iran (12), only 0.6% of HD patients showed seropositivity for this infection (13).…”

Section: Discussionmentioning

confidence: 99%

High Prevalence of HTLV-1 Infection Among Hemodialysis Patients in Neyshabur, Northeast of Iran: A Clinical Trial

et al. 2019

View full text Add to dashboard Cite

Background: Human T-lymphotropic virus type 1 (HTLV-1) infection has known to be endemic in various regions of the world, including northeastern Iran. Objectives: This study aimed to determine the prevalence of HTLV-1 infection and its related factors among hemodialysis (HD) patients in Neyshabur, northeast of Iran. Methods: Serum samples of 138 HD patients were screened for HTLV-1 antibodies using enzyme-linked immunosorbent assay, and seroreactive samples were confirmed by a line immunoassay. Results: The participants included 76 (55.1%) males and 62 (44.9%) females aged 12-84 years. HTLV-1 seropositivity was detected in 20 (14.5%) cases, all of which were confirmed by the line immunoassay. No significant difference was observed between males and females (10.5% vs. 19.3%; P = 0.143). However, there was a significant association between HTLV-1 seropositivity and patients' age (P = 0.028). Conclusions: The prevalence of HTLV-1 infection among HD patients in northeastern Iran was considerably higher than that reported from other endemic areas. It seems that more specific preventive measures are required to be applied by local health authorities to control the infection.

show abstract

Section: Discussionmentioning

confidence: 99%

High Prevalence of HTLV-1 Infection Among Hemodialysis Patients in Neyshabur, Northeast of Iran: A Clinical Trial

et al. 2019

View full text Add to dashboard Cite

show abstract

Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran

Hedayati-Moghaddam

Esfehani

Hajj

et al. 2022

Viruses

View full text Add to dashboard Cite

Background: The epidemiology and prevalence of the Human T-cell leukemia virus type-1 (HTLV-1) infection represent a recommended priority by global health agencies. An in-depth revision to update the status of this infection in countries including those of the Eastern Mediterranean Regional Office (EMRO) of the World Health Organization is hence required. Methods: Ninety-seven studies evaluating the HTLV-1 infection in low- and high-risk populations in EMRO countries were retrieved from the international electronic databases and were used to assess the epidemiological status of the infection in these countries. Results: Most epidemiologic reports were published from Iran, with more than 50% of Iranian prisoners and around 4% of healthy individuals reported to have the infection. In Egypt, a considerable prevalence of the virus spans around 1.11% of blood donors. Foci of HTLV-1 infection are also present in some countries and require a careful epidemiological evaluation. In the other EMRO countries, a lower prevalence that does not exceed 1% was reported. Conclusion: The epidemiology and prevalence of HTLV-1 in the EMRO countries require a tight revision and update. Published studies reveal a scarce distribution of the virus in the African countries of EMRO, while a lower prevalence is denoted in the Asian countries of EMRO, except in Iran, where the prevalence is high.

show abstract

First Report of the Prevalence of Human T-Lymphotropic Virus Type 1 (HTLV-1) for Hemodialysis Patients in Tehran

Cited by 2 publications

References 26 publications

High Prevalence of HTLV-1 Infection Among Hemodialysis Patients in Neyshabur, Northeast of Iran: A Clinical Trial

High Prevalence of HTLV-1 Infection Among Hemodialysis Patients in Neyshabur, Northeast of Iran: A Clinical Trial

Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran

Contact Info

Product

Resources

About